Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network
Philip L. Johnson, Brian C. Samuels, Stephanie D. Fitz, et al.
Physiology & Behavior (2012) Vol. 107, Iss. 5, pp. 733-742
Open Access | Times Cited: 102

Showing 26-50 of 102 citing articles:

OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2-INDUCED PANIC-ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSES
Philip L. Johnson, Lauren M. Federici, Stephanie D. Fitz, et al.
Depression and Anxiety (2015) Vol. 32, Iss. 9, pp. 671-683
Open Access | Times Cited: 62
Attenuated orexinergic signaling underlies depression-like responses induced by daytime light deficiency
Sean Deats, Widya Adidharma, Joseph S. Lonstein, et al.
Neuroscience (2014) Vol. 272, pp. 252-260
Open Access | Times Cited: 59
Hypocretins, Neural Systems, Physiology, and Psychiatric Disorders
Shi‐Bin Li, Jeff R. Jones, Luı́s de Lecea
Current Psychiatry Reports (2016) Vol. 18, Iss. 1
Closed Access | Times Cited: 59
Etiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacks
Philip L. Johnson, Lauren M. Federici, Anantha Shekhar
Neuroscience & Biobehavioral Reviews (2014) Vol. 46, pp. 429-454
Open Access | Times Cited: 58
Orexin 1 receptor antagonists in compulsive behavior and anxiety: possible therapeutic use
Emilio Merlo Pich, Sergio Melotto
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 57
Orexin, orexin receptor antagonists and central cardiovascular control
Pascal Carrive
Frontiers in Neuroscience (2013) Vol. 7
Open Access | Times Cited: 57
Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humans
Giacomo Salvadore, Pascal Bonaventure, Anantha Shekhar, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 40
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1607-1667
Closed Access | Times Cited: 13
Neurocircuitry and Neuroanatomy in Panic Disorder: A Systematic Review
Peter Kyriakoulis, Clarissa Wijaya, Laiana A. Quagliato, et al.
ALPHA PSYCHIATRY (2025) Vol. 26, Iss. 1
Closed Access
Orexins (hypocretins) contribute to fear and avoidance in rats exposed to a single episode of footshocks
Xiaoyu Chen, Huiying Wang, Lin Zhang, et al.
Brain Structure and Function (2013) Vol. 219, Iss. 6, pp. 2103-2118
Closed Access | Times Cited: 54
Nucleus incertus Orexin2 receptors mediate alcohol seeking in rats
Hanna E. Kastman, Anna Błasiak, Leigh C. Walker, et al.
Neuropharmacology (2016) Vol. 110, pp. 82-91
Closed Access | Times Cited: 46
Cross-species pharmacological characterization of the allylglycine seizure model in mice and larval zebrafish
Karine Leclercq, Tatiana Afrikanova, Mélanie Langlois, et al.
Epilepsy & Behavior (2015) Vol. 45, pp. 53-63
Open Access | Times Cited: 44
Orexin and Central Modulation of Cardiovascular and Respiratory Function
Pascal Carrive, Tomoyuki Kuwaki
Current topics in behavioral neurosciences (2016), pp. 157-196
Open Access | Times Cited: 44
Orexin as a modulator of fear-related behavior: Hypothalamic control of noradrenaline circuit
Shingo Soya, Takeshi Sakurai
Brain Research (2018) Vol. 1731, pp. 146037-146037
Open Access | Times Cited: 44
Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation
Pascal Bonaventure, Christine Dugovic, Brock T. Shireman, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 42
Do orexin/hypocretin neurons signal stress or reward?
Daria Peleg‐Raibstein, Denis Burdakov
Peptides (2021) Vol. 145, pp. 170629-170629
Open Access | Times Cited: 27
The Hypocretin System and Psychiatric Disorders
Fabio Pizza, Michele Magnani, Camilla Indrio, et al.
Current Psychiatry Reports (2013) Vol. 16, Iss. 2
Closed Access | Times Cited: 40
Differential Effect of Orexin-1 and CRF-1 Antagonism on Stress Circuits: a fMRI Study in the Rat with the Pharmacological Stressor Yohimbine
Alessandro Gozzi, Stefano Lepore, Elena Vicentini, et al.
Neuropsychopharmacology (2013) Vol. 38, Iss. 11, pp. 2120-2130
Open Access | Times Cited: 39
Orexin receptors within the nucleus accumbens shell mediate the stress but not drug priming-induced reinstatement of morphine conditioned place preference
Keke Qi, Chuguang Wei, Yonghui Li, et al.
Frontiers in Behavioral Neuroscience (2013) Vol. 7
Open Access | Times Cited: 38
The orexin-1 receptor antagonist SB-334867 attenuates anxiety in rats exposed to cat odor but not the elevated plus maze: An investigation of Trial 1 and Trial 2 effects
Lauren Staples, Jennifer L. Cornish
Hormones and Behavior (2014) Vol. 65, Iss. 3, pp. 294-300
Closed Access | Times Cited: 38
Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes
Michael G. Gottschalk, Jan Richter, Christiane Ziegler, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 33
Activation of orexin/hypocretin neurons is associated with individual differences in cued fear extinction
Amanda C. Sharko, Jim R. Fadel, Kris F. Kaigler, et al.
Physiology & Behavior (2016) Vol. 178, pp. 93-102
Open Access | Times Cited: 32
The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse
Morgan H. James, Jennifer E. Fragale, Shayna L. O’Connor, et al.
Neuropharmacology (2020) Vol. 183, pp. 108359-108359
Open Access | Times Cited: 29
Reviewing the role of the orexinergic system and stressors in modulating mood and reward-related behaviors
Salar Vaseghi, Shahram Zarrabian, Abbas Haghparast
Neuroscience & Biobehavioral Reviews (2021) Vol. 133, pp. 104516-104516
Closed Access | Times Cited: 23
Orexin Receptor Antagonists in the Treatment of Depression: A Leading Article Summarising Pre-clinical and Clinical Studies
Harry Fagan, Edward G. Jones, David S. Baldwin
CNS Drugs (2022) Vol. 37, Iss. 1, pp. 1-12
Closed Access | Times Cited: 17

Scroll to top